...
首页> 外文期刊>Hospital pharmacy. >Clinical and Financial Impact of Pharmacist Involvement in Discharge Medication Reconciliation at an Academic Medical Center: A Prospective Pilot Study
【24h】

Clinical and Financial Impact of Pharmacist Involvement in Discharge Medication Reconciliation at an Academic Medical Center: A Prospective Pilot Study

机译:药剂师参与学术医学中心出院药物调和的临床和财务影响:一项前瞻性先导研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Medication reconciliation is one of the more challenging aspects of inpatient care, and its accuracy is paramount to safe transitions of care. Studies have shown that pharmacists have a role in medication reconciliation through improving patient safety and avoiding costs associated with medication errors. The wide-scale use of pharmacists in this process has been limited by time constraints, cost, and lack of resources.Objective: This study evaluates the impact of pharmacists in resolving medication errors, decreasing readmission rates, and reducing institutional costs during the discharge medication reconciliation process.Methods: Pharmacists evaluated discharge medication reconciliation documentation for patients to determine its accuracy, the accuracy of the admission reconciliation documentation, and any potential issues unrelated to accuracy. Analysis of these data determined the time required for pharmacist involvement, the number of errors identified by pharmacists, the quality of pharmacist interventions, the cost avoidance for each error, and the overall impact on hospital readmission. Results: During the 7-week study period, pharmacists performed 67 discharge medication reviews and identified 84 errors. Seventy-five percent were considered to be significant and 6% were considered to be serious. The 30-day readmission rate in the study cohort was 18% compared with 20% in the control group. Based on the clinical severity scale and pharmacist salaries, pharmacist interventions resulted in $42,300 in cost avoidance.Conclusion: Pharmacists involved in this pilot discharge process identified and resolved significant errors on medication reconciliation orders that resulted in a financial benefit to the institution.
机译:背景:药物和解是住院治疗中更具挑战性的方面之一,其准确性对于安全过渡医疗至关重要。研究表明,药剂师可通过改善患者安全性和避免与用药错误相关的费用在用药和解中发挥作用。目的:这项研究评估了药剂师在解决用药错误,降低再入院率以及降低出院用药期间的机构成本方面的影响,该过程中药剂师的广泛使用受到限制。方法:药剂师为患者评估了出院药物对账文件,以确定其准确性,入院对账文件的准确性以及与准确性无关的任何潜在问题。对这些数据的分析确定了药剂师参与所需的时间,药剂师发现的错误数量,药剂师干预的质量,避免每个错误的成本以及对医院再入院的总体影响。结果:在为期7周的研究期内,药剂师进行了67次出院药物复查,发现了84个错误。百分之七十五被认为是重要的,百分之六被认为是严重的。研究组的30天再入院率为18%,而对照组为20%。根据临床严重程度量表和药剂师的薪水,药剂师的干预可避免$ 42,300的费用。结论:参与该试点出院流程的药剂师确定并解决了药品核对单上的重大错误,从而为该机构带来了经济利益。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号